An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (Pcos): Post-pubertal improve pcos's features

49Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

Complete animal models investigating the pathogenesis and treatment of polycystic ovarian syndrome (PCOS) are not completely established. Although dehydroepiandrosterone (DHEA)-induced pre-pubertal rat model for PCOS has been widely used, the model exhibits weaknesses such as decreased ovary weight. Here, we report an innovative DHEA-induced PCOS model that addresses limitations of the pre-pubertal model. The 21-day-old (pre-pubertal) and 42-day-old (post-pubertal) female rats were subcutaneously injected with DHEA (60 mg/kg body weight) daily for up to 20-30 days. The post-pubertal model showed a steady increase in ovary weight and the number of ovarian cysts as well as uterine weight and thickness, which may be key features of PCOS, compared with the pre-pubertal model. Therefore, a post-pubertal PCOS model induced by DHEA may be an improved model to investigate the etiology of PCOS and development of therapeutic interventions.

Cite

CITATION STYLE

APA

Kim, E. J., Jang, M., Choi, J. H., Park, K. S., & Cho, I. H. (2018). An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (Pcos): Post-pubertal improve pcos’s features. Frontiers in Endocrinology, 9, 1–7. https://doi.org/10.3389/fendo.2018.00735

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free